143 related articles for article (PubMed ID: 21264542)
1. Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma.
Mahipal A; Mcdonald MJ; Witkiewicz A; Carr BI
Med Oncol; 2012 Mar; 29(1):134-9. PubMed ID: 21264542
[TBL] [Abstract][Full Text] [Related]
2. The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.
Ueda S; Ogata S; Tsuda H; Kawarabayashi N; Kimura M; Sugiura Y; Tamai S; Matsubara O; Hatsuse K; Mochizuki H
Pancreas; 2004 Jul; 29(1):e1-8. PubMed ID: 15211117
[TBL] [Abstract][Full Text] [Related]
3. Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer.
Ueda S; Hatsuse K; Tsuda H; Ogata S; Kawarabayashi N; Takigawa T; Einama T; Morita D; Fukatsu K; Sugiura Y; Matsubara O; Mochizuki H
Mod Pathol; 2006 Jun; 19(6):788-96. PubMed ID: 16575403
[TBL] [Abstract][Full Text] [Related]
4. Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma.
Feng J; Adsay NV; Kruger M; Ellis KL; Nagothu K; Majumdar AP; Sarkar FH
Pancreas; 2002 Nov; 25(4):342-9. PubMed ID: 12409827
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma.
Giaginis C; Tsourouflis G; Zizi-Serbetzoglou A; Kouraklis G; Chatzopoulou E; Dimakopoulou K; Theocharis SE
Pathol Oncol Res; 2010 Jun; 16(2):267-76. PubMed ID: 19949912
[TBL] [Abstract][Full Text] [Related]
6. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
Foo WC; Rashid A; Wang H; Katz MH; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
Hum Pathol; 2013 Jun; 44(6):1024-30. PubMed ID: 23260327
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer.
Guo M; Luo G; Liu C; Cheng H; Lu Y; Jin K; Liu Z; Long J; Liu L; Xu J; Huang D; Ni Q; Yu X
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399694
[TBL] [Abstract][Full Text] [Related]
8. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH
Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of the membrane skeleton protein beta1-spectrin (SPTBN1) is associated with worsened prognosis in pancreatic cancer.
Jiang X; Gillen S; Esposito I; Giese NA; Michalski CW; Friess H; Kleeff J
Histol Histopathol; 2010 Dec; 25(12):1497-506. PubMed ID: 20886430
[TBL] [Abstract][Full Text] [Related]
10. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
11. Association of subcellular localization of TEAD transcription factors with outcome and progression in pancreatic ductal adenocarcinoma.
Drexler R; Fahy R; Küchler M; Wagner KC; Reese T; Ehmke M; Feyerabend B; Kleine M; Oldhafer KJ
Pancreatology; 2021 Jan; 21(1):170-179. PubMed ID: 33317954
[TBL] [Abstract][Full Text] [Related]
12. Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma.
Hu D; Ansari D; Zhou Q; Sasor A; Hilmersson KS; Bauden M; Jiang Y; Andersson R
BMC Cancer; 2018 Nov; 18(1):1096. PubMed ID: 30419838
[TBL] [Abstract][Full Text] [Related]
13. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
[TBL] [Abstract][Full Text] [Related]
14. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
[TBL] [Abstract][Full Text] [Related]
15. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma.
Jiang NY; Woda BA; Banner BF; Whalen GF; Dresser KA; Lu D
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1648-52. PubMed ID: 18628415
[TBL] [Abstract][Full Text] [Related]
16. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
17. High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Liang JJ; Zhu S; Bruggeman R; Zaino RJ; Evans DB; Fleming JB; Gomez HF; Zander DS; Wang H
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2598-604. PubMed ID: 20732965
[TBL] [Abstract][Full Text] [Related]
18. The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.
Takeda T; Izumi H; Kitada S; Uramoto H; Tasaki T; Zhi L; Guo X; Kawatsu Y; Kimura T; Horie S; Nabeshima A; Noguchi H; Wang KY; Sasaguri Y; Kohno K; Yamada S
Tumour Biol; 2014 Oct; 35(10):10555-69. PubMed ID: 25060178
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
[TBL] [Abstract][Full Text] [Related]
20. Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma.
Kim HS; Kim GY; Lim SJ; Kim YW
Pathology; 2010 Dec; 42(7):655-60. PubMed ID: 21080875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
